Evidence map›Paper›PMID 40637794›Full record

ArticleFunctional & integrative genomics2025

Efficient gene editing of BMP15, GDF9, and MSTN-but not the imprinted CLPG gene-in goat embryos via electrotransfection and handmade cloning.

Mehdi Hajian, Ahmad Pirali, Seyed Hossein Hosseini Moghaddam, Reza Moradi-Hajidavaloo, Shiva Rouhollahi Varnosfaderani, Mina Jozi, Tayebeh Izadi, Nima Tanhaie-Vash, Wilfried Kues, Mohammad-Hossein Nasr-Esfahani and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Functional & integrative genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mehdi Hajian *Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Ahmad Pirali *Department of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Seyed Hossein Hosseini MoghaddamDepartment of Animal Science, Faculty of Agricultural Sciences, University of Guilan, PO Box 41635-1314, Rasht, Iran.
Reza Moradi-HajidavalooDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Shiva Rouhollahi VarnosfaderaniDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Mina JoziDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Tayebeh IzadiDepartment of Cellular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Nima Tanhaie-VashDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Wilfried KuesFederal Research Institute for Animal Health, Friedrich-Loeffler-Institut, 31535, Neustadt Rbge, Germany.
Mohammad-Hossein Nasr-EsfahaniDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran.
Farnoosh JafarpourDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran. jafarpour.farnoosh@gmail.com.
Shahin EghbalsaiedDepartment of Animal Biotechnology, Reproductive Biomedicine Research Center, Royan Institute for Biotechnology, ACECR, PO Box 816513-1378, Isfahan, Iran. shahin080@gmail.com.

Funding

Alexander von Humboldt-Stiftung Ref 3.4-IRN-1191261-GF-EIranian Vice President for Science CT1402091612
6 · The paper itself

Abstract

CRISPR/Cas9 technology represents a powerful tool for advancing livestock breeding by enabling precise, on-target gene edits without the genomic mixing associated with traditional introgression methods. In this study, we employed a dual gRNA-based CRISPR/Cas9 strategy to induce targeted deletions and indel mutations in both reproductive and growth-related genes. These included the metacentric genes bone morphogenetic protein 15 (BMP15) and growth differentiation factor 9 (GDF9), which are associated with increased ovulation rate and litter size, as well as the telomeric genes myostatin (MSTN) and callipyge (CLPG), which are linked to muscle development and enhanced meat production. We employed an optimized electrotransfection protocol consisting of 10-20 µg of each plasmid DNA, 250 µL OptiMEM-GlutaMAX, and one million goat fibroblast cells. The electroporation was performed using a Bio-Rad system in a 4-mm cuvette, with two 10-millisecond pulses at 270 volts, separated by a 10-second interval. This protocol enabled efficient genome editing of goat embryonic fibroblast cells, which were subsequently used to generate cloned embryos via handmade somatic cell nuclear transfer (SCNT), involving manual enucleation and cell-oocyte fusion steps. Sequencing revealed high mutation rates (78-97%) and a predominance of biallelic edits in BMP15, GDF9, and MSTN. Notably, MSTN gRNAs with a 7-bp overlapping sequence at their 3' ends showed a high editing efficiency. In contrast, the imprinted CLPG gene exhibited a significantly lower mutation rate (~ 30%), likely due to epigenetic constraints. While overall mutation rates did not differ significantly between metacentric and telomeric genes, on-target deletions were more frequent in metacentric genes (43%) than in telomeric ones (20%). Embryo development rates from gene-edited cells were comparable to those from non-edited controls. These findings underscore the utility of combining electrotransfection with SCNT for efficient editing of non-imprinted genes and highlight the need for improved strategies to overcome barriers in editing imprinted loci.

Indexed as

Bone Morphogenetic Protein 15Gene EditingGoatsGrowth Differentiation Factor 9MyostatinAnimalsCloning, OrganismCRISPR-Cas SystemsElectroporationEmbryo, MammalianFemaleGenomic ImprintingNuclear Transfer TechniquesBone Morphogenetic Protein 15Growth Differentiation Factor 9MyostatinCRISPR/Cas9ElectrotransfectionGene editingHandmade cloningImprinted genesSomatic cell nuclear transfer (SCNT)

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.